OpenFilings

REGENERON PHARMACEUTICALS, INC.

Form10-Q

Report Period2026-03-31

Date Filed2026-04-29

Time Filed06:54:54

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-Q
CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A)
CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A)
CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C SECTION 1350
Filing on SEC Edgar